David Pérol

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Postoperative Pain

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of the National Cancer Institute

JMIR research protocols

Journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Allison Voisin, Catherine Terret, Camille Schiffler, Anne-Sophie Bidaux, Helene Vanacker, Marlène Perrin-Niquet, Maud Barbery, Armelle Vinceneux, Lauriane Eberst, Pierre Stéphan, Gwenaele Garin, Dany Spaggiari, David Pérol, Yenkel Grinberg-Bleyer, Philippe Alexandre Cassier
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Allison Voisin, Catherine Terret, Camille Schiffler, Anne-Sophie Bidaux, Helene Vanacker, Marlène Perrin-Niquet, Maud Barbery, Armelle Vinceneux, Lauriane Eberst, Pierre Stéphan, Gwenaele Garin, Dany Spaggiari, David Pérol, Yenkel Grinberg-Bleyer, Philippe Alexandre Cassier
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Allison Voisin, Catherine Terret, Camille Schiffler, Anne-Sophie Bidaux, Helene Vanacker, Marlène Perrin-Niquet, Maud Barbery, Armelle Vinceneux, Lauriane Eberst, Pierre Stéphan, Gwenaele Garin, Dany Spaggiari, David Pérol, Yenkel Grinberg-Bleyer, Philippe Alexandre Cassier
Xevinapant combined with pembrolizumab in patients with advanced, pretreated colorectal and pancreatic cancer: results of the phase 1b/2 CATRIPCA trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alison Antoine, David Pérol, Mathieu Robain, Suzette Delaloge, Christine Lasset, Youenn Drouet
Target trial emulation to assess real-world efficacy in the ESME metastatic breast cancer cohort. Journal of the National Cancer Institute (2023)
Lidia Delrieu, Vincent Pialoux, Olivia Pérol, Magali Morelle, Agnès Martin, Christine M Friedenreich, Olivia Febvey-Combes, David Pérol, Elodie Belladame, Michel Clémençon, Eva Roitmann, Armelle Dufresne, Thomas Bachelot, Pierre Etienne Heudel, Marina Touillaud, Olivier Trédan, Beatrice Fervers
Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study. JMIR mHealth and uHealth 8 (1) (2020)
Véronique Peres-Bachelot, Ellen Blanc, Nadia Oussaid, David Pérol, Anne Laure Daunizeau-Walker, Stéphanie Pouderoux, Patrice Peyrat, Michel Rivoire, Aurélien Dupré
A 96-hour continuous wound infiltration with ropivacaine reduces analgesic consumption after liver resection: A randomized, double-blind, controlled trial. Journal of surgical oncology 119 (1) (2018)
Lidia Delrieu, Olivia Pérol, Beatrice Fervers, Christine M Friedenreich, Jeff K Vallance, Olivia Febvey-Combes, David Pérol, Brice Canada, Eva Roitmann, Armelle Dufresne, Thomas Bachelot, Pierre Etienne Heudel, Olivier Trédan, Marina Touillaud, Vincent Pialoux
A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial. JMIR research protocols 7 (8) (2018)